Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2009. Start Trial.
Date Value
June 30, 2026 -80.49%
March 31, 2026 -57.08%
December 31, 2025 24.67%
September 30, 2025 -228.1%
June 30, 2025 -86.59%
March 31, 2025 -274.3%
December 31, 2024 -48.35%
September 30, 2024 -160.8%
June 30, 2024 -285.2%
March 31, 2024 -67.39%
December 31, 2023 -27.08%
September 30, 2023 -376.3%
June 30, 2023 -54.04%
March 31, 2023 -174.2%
December 31, 2022 -41.50%
September 30, 2022 -28.99%
June 30, 2022 -6.87%
March 31, 2022 -23.64%
December 31, 2021 -41.59%
September 30, 2021 6.10%
June 30, 2021 -16.76%
March 31, 2021 -50.29%
December 31, 2020 -18.64%
September 30, 2020 -33.15%
June 30, 2020 -42.39%
Date Value
March 31, 2020 -52.16%
December 31, 2019 -3.40%
September 30, 2019 1.57%
June 30, 2019 -52.82%
March 31, 2019 -32.96%
December 31, 2018 -2.87%
September 30, 2018 -11.73%
June 30, 2018 -27.59%
March 31, 2018 -33.43%
December 31, 2017 4.47%
September 30, 2017 -102.4%
June 30, 2017 -60.69%
March 31, 2017 -93.59%
December 31, 2016 -52.76%
September 30, 2016 9.66%
June 30, 2016 13.99%
March 31, 2016 -87.22%
December 31, 2015 -17.72%
September 30, 2015 31.00%
June 30, 2015 -89.07%
March 31, 2015 -81.82%
December 31, 2014 2.43%
September 30, 2014 -61.05%
June 30, 2014 -129.1%
March 31, 2014 -90.12%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Agilent Technologies, Inc. 19.28%
Bio-Rad Laboratories, Inc. 57.05%
Bruker Corp. -6.07%
Azenta, Inc. -0.95%
Danaher Corp. 18.42%